Ending the Prescription Drug Kickback Act of 2023
- Last Action
- 4/19/2023
Actions
- 2023-04-19Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2023-04-19Introduced in Senate
CRS Summary
As of 2023-04-19 (00)
Ending the Prescription Drug Kickback Act of 2023
This bill generally prohibits prescription drug manufacturers from providing rebates to pharmacy benefit managers (PBMs) or private health insurance plans.
Specifically, the bill eliminates the safe harbor for rebates, or other payments, provided to PBMs that are intended to influence the applicable cost-sharing tier of the drug (e.g., placing the drug in a more favorable formulary tier).
The bill further prohibits health insurance plans from receiving such rebates with respect to a prescription drug covered by the plan. Plans also must ensure PBMs do not receive any such rebates.
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.